D'Orazio & Associates, Inc. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 151 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
D'Orazio & Associates, Inc. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$23,000
+155.6%
1,500
+200.0%
0.01%
+166.7%
Q3 2017$9,000
-62.5%
500
-66.7%
0.00%
-66.7%
Q2 2017$24,000
+242.9%
1,500
+200.0%
0.01%
+200.0%
Q1 2017$7,0005000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,791,805$64,992,0003.92%
Birchview Capital, LP 80,000$1,371,0000.93%
Profit Investment Management, LLC 78,154$1,339,0000.93%
Soleus Capital Management, L.P. 298,600$5,118,0000.80%
GLOBEFLEX CAPITAL L P 196,026$3,360,0000.73%
DENALI ADVISORS LLC 89,300$1,531,0000.64%
ARMISTICE CAPITAL, LLC 1,965,000$33,680,0000.57%
FinTrust Capital Advisors, LLC 105,982$1,816,0000.48%
Zebra Capital Management LLC 22,878$392,0000.48%
HUSSMAN STRATEGIC ADVISORS, INC. 124,000$2,125,0000.47%
View complete list of VANDA PHARMACEUTICALS INC shareholders